Presentations at the 2018 American Academy of Neurology Highlight the Broad Potential of Antisense Drugs for Neurological Diseases

Ionis Pharmaceuticals (PRNewsFoto/Ionis Pharmaceuticals, Inc.)CARLSBAD, Calif., April 17, 2018 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced that Ionis and its collaborators will present data from its neurological disease programs at the 70th American Academy of Neurology (AAN)…

Share this post